Total Wealth Planning & Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Buy
52,580
+1,650
+3% +$43.9K 1.09% 15
2025
Q4
$1.27M Buy
+50,930
New +$1.28M 0.94% 20
2025
Q2
$922K Buy
38,048
+10,189
+37% +$238K 0.75% 32
2025
Q1
$706K Buy
27,859
+2,716
+11% +$71.1K 0.67% 40
2024
Q4
$667K Buy
+25,143
New +$682K 0.61% 42

Other funds holding PFE

Total Wealth Planning & Management's PFE Position: Q1 2026 in Review

Total Wealth Planning & Management increased its Pfizer (PFE) stake by 3.2% in Q1 2026, buying an estimated $43.9K and bringing the position to 52,580 shares worth $1.48M. The position accounts for 1.09% of the portfolio, ranked #15.

Total Wealth Planning & Management first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Total Wealth Planning & Management held 52,580 shares of Pfizer worth $1.48M as of Q1 2026.
  • Total Wealth Planning & Management bought 1,650 Pfizer shares in Q1 2026, an estimated $43.9K.
  • Pfizer made up 1.09% of Total Wealth Planning & Management's portfolio in Q1 2026, its #15 holding.
  • Total Wealth Planning & Management first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Total Wealth Planning & Management's 13F filing for Q1 2026, filed 5 May 2026.